Guardian Pharmacy Services, Inc.
Business
Guardian Pharmacy Services is an institutional pharmacy provider serving long-term care facilities (LTCFs), including assisted living, behavioral health, and skilled nursing facilities across 38 states. The company operates 61 pharmacies delivering compliance-packaged medications, clinical consulting, and technology-enabled pharmacy services to approximately 205,000 residents. Revenue derives primarily from Medicare Part D payors, Medicaid, and commercial insurers through facility and health plan contracts.
Summary from 10-K filed 2026-03-11
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Revenues | 1,449 | 1,228 | 1,046 | |
| Cost of goods sold | 1,156 | 984 | 838 | |
| Gross profit | 293 | 244 | 208 | |
| Selling, general, and administrative expenses | 220 | 307 | 167 | |
| Operating income (loss) | 73 | −63 | 41 | |
| Interest expense | 665,000 | 3 | 3 | |
| Other expense (income), net | −1 | 279,000 | 367,000 | |
| Total other expenses (income) | −722,000 | 4 | 3 | |
| Income (loss) before income taxes | 73 | −66 | 38 | |
| Provision for income taxes | 24 | 5 | 0 | |
| Net income (loss) | 49 | −71 | 38 | |
| Less net income attributable to Guardian Pharmacy, LLC prior to the Corporate Reorganization | 0 | 23 | 24 | |
| Less net income (loss) attributable to non-controlling interests | −261,000 | 16 | 14 | |
| Net income (loss) attributable to Guardian Pharmacy Services, Inc. | 49 | −110 | — |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 66 | 5 | 752,000 | — | |
| Accounts receivable, net | 102 | 97 | 77 | — | |
| Inventories | 43 | 41 | 37 | — | |
| Other current assets | 11 | 10 | 15 | — | |
| Total current assets | 222 | 152 | 130 | — | |
| Property and equipment, net | 56 | 50 | 45 | — | |
| Intangible assets, net | 18 | 15 | 12 | — | |
| Goodwill | 80 | 69 | 56 | — | |
| Operating lease right-of-use assets | 35 | 29 | 28 | — | |
| Deferred tax assets | 2 | 5 | 0 | — | |
| Other assets | 436,000 | 383,000 | 358,000 | — | |
| Total assets | 413 | 321 | 271 | — | |
| Accounts payable | 116 | 102 | 86 | — | |
| Accrued compensation | 15 | 14 | 17 | — | |
| Operating leases, current portion | 7 | 7 | 6 | — | |
| Other current liabilities | 22 | 20 | 16 | — | |
| Total current liabilities | 161 | 144 | 138 | — | |
| Operating leases, net of current portion | 30 | 23 | 23 | — | |
| Other liabilities | 4 | 3 | 31 | — | |
| Total liabilities | 195 | 171 | 211 | — | |
| Commitments and contingencies (see Note 6) | — | — | — | — | |
| Members' equity | 0 | 0 | — | — | |
| Additional paid-in capital | 139 | 125 | — | — | |
| Retained earnings | 66 | 17 | — | — | |
| Non-controlling interests | 12 | 7 | 32 | — | |
| Total equity | 218 | 150 | 60 | 76 | |
| Total liabilities and equity | 413 | 321 | 271 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Net income (loss) | 49 | −71 | 38 | |
| Depreciation and amortization | 22 | 20 | 18 | |
| Share-based compensation expense | 14 | 131 | −6 | |
| Provision for losses on accounts receivable | 5 | 6 | 5 | |
| Change in deferred tax asset | 3 | 0 | — | |
| Other | 1 | 767,000 | 283,000 | |
| Accounts receivable | −9 | −25 | −14 | |
| Inventories | −877,000 | −1 | 4 | |
| Other current assets | −2 | −2 | −5 | |
| Accounts payable | 16 | 13 | 6 | |
| Accrued compensation | 618,000 | −3 | 3 | |
| Other operating liabilities | 1 | −11 | 21 | |
| Net cash provided by operating activities | 100 | 58 | 71 | |
| Purchases of property and equipment | −20 | −16 | −15 | |
| Payment for acquisitions | −13 | −15 | −985,000 | |
| Other | 736,000 | 671,000 | 2 | |
| Net cash used in investing activities | −32 | −30 | −13 | |
| Proceeds from equity offering, net of underwriter fees | 29 | 120 | — | |
| Payments of equity offering costs | −2 | −4 | — | |
| Borrowings from notes payable | 0 | 15 | — | |
| Repayment of notes payable | −497,000 | −38 | −4 | |
| Borrowings from line of credit | 0 | 189 | 270 | |
| Repayments of line of credit | 0 | −198 | −265 | |
| Principal payments on finance lease obligations | −4 | −4 | −4 | |
| Payments related to acquisitions | −3 | 0 | −325,000 | |
| Contributions from non-controlling interests | 2 | 3 | 889,000 | |
| Distributions to non-controlling interests | −458,000 | −14 | −16 | |
| Member distributions | 0 | −36 | −38 | |
| Other | 500,000 | −160,000 | — | |
| Net cash used in financing activities | −7 | −24 | −57 | |
| Net change in cash and cash equivalents | 61 | 4 | 145,000 | |
| Cash paid during the year for interest | 650,000 | 3 | 3 | |
| Cash paid during the year for income taxes | 22 | 0 | — | |
| Purchases of property and equipment through finance leases | 5 | 4 | 6 | |
| Accrued and capitalized offering costs recorded to additional paid-in capital | 0 | 9 | — | |
| Non-cash equity contributions from non-controlling members | 4 | 6 | 0 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Guardian Pharmacy Services, Inc.'s CIK number?
Guardian Pharmacy Services, Inc.'s SEC CIK number is 0001802255 (1802255). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Guardian Pharmacy Services, Inc.'s SEC filings?
All of Guardian Pharmacy Services, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Guardian Pharmacy Services, Inc. last report earnings?
Guardian Pharmacy Services, Inc. (GRDN) most recently filed an earnings 8-K with the SEC on May 6, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001193125-26-208989). This is Guardian Pharmacy Services, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Guardian Pharmacy Services, Inc.'s most recent earnings 8-K?
Guardian Pharmacy Services, Inc.'s latest earnings 8-K (Item 2.02) was filed May 6, 2026 under accession 0001193125-26-208989. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Guardian Pharmacy Services, Inc.'s latest earnings 8-K →
Look up any company's CIK number →